Engineering the acyltransferase domain of epothilone polyketide synthase to alter the substrate specificity.
AT
Domain swap
Epothilone
Polyketide synthase
Substrate specificity
Journal
Microbial cell factories
ISSN: 1475-2859
Titre abrégé: Microb Cell Fact
Pays: England
ID NLM: 101139812
Informations de publication
Date de publication:
21 Apr 2021
21 Apr 2021
Historique:
received:
04
01
2021
accepted:
07
04
2021
entrez:
22
4
2021
pubmed:
23
4
2021
medline:
5
10
2021
Statut:
epublish
Résumé
Polyketide synthases (PKSs) include ketone synthase (KS), acyltransferase (AT) and acyl carrier protein (ACP) domains to catalyse the elongation of polyketide chains. Some PKSs also contain ketoreductase (KR), dehydratase (DH) and enoylreductase (ER) domains as modification domains. Insertion, deletion or substitution of the catalytic domains may lead to the production of novel polyketide derivatives or to the accumulation of desired products. Epothilones are 16-membered macrolides that have been used as anticancer drugs. The substrate promiscuity of the module 4 AT domain of the epothilone PKS (EPOAT4) results in production of epothilone mixtures; substitution of this domain may change the ratios of epothilones. In addition, there are two dormant domains in module 9 of the epothilone PKS. Removing these redundant domains to generate a simpler and more efficient assembly line is a desirable goal. The substitution of module 4 drastically diminished the activity of epothilone PKS. However, with careful design of the KS-AT linker and the post-AT linker, replacing EPOAT4 with EPOAT2, EPOAT6, EPOAT7 or EPOAT8 (specifically incorporating methylmalonyl-CoA (MMCoA)) significantly increased the ratio of epothilone D (4) to epothilone C (3) (the highest ratio of 4:3 = 4.6:1), whereas the ratio of 4:3 in the parental strain Schlegelella brevitalea 104-1 was 1.4:1. We also obtained three strains by swapping EPOAT4 with EPOAT3, EPOAT5, or EPOAT9, which specifically incorporate malonyl-CoA (MCoA). These strains produced only epothilone C, and the yield was increased by a factor of 1.8 compared to that of parental strain 104-1. Furthermore, mutations of five residues in the AT domain identified Ser310 as the critical factor for MMCoA recognition in EPOAT4. Then, the mutation of His308 to valine or tyrosine combined with the mutation of Phe310 to serine further altered the product ratios. At the same time, we successfully deleted the inactive module 9 DH and ER domains and fused the ΨKR domain with the KR domain through an ~ 25-residue linker to generate a productive and simplified epothilone PKS. These results suggested that the substitution and deletion of catalytic domains effectively produces desirable compounds and that selection of the linkers between domains is crucial for maintaining intact PKS catalytic activity.
Sections du résumé
BACKGROUND
BACKGROUND
Polyketide synthases (PKSs) include ketone synthase (KS), acyltransferase (AT) and acyl carrier protein (ACP) domains to catalyse the elongation of polyketide chains. Some PKSs also contain ketoreductase (KR), dehydratase (DH) and enoylreductase (ER) domains as modification domains. Insertion, deletion or substitution of the catalytic domains may lead to the production of novel polyketide derivatives or to the accumulation of desired products. Epothilones are 16-membered macrolides that have been used as anticancer drugs. The substrate promiscuity of the module 4 AT domain of the epothilone PKS (EPOAT4) results in production of epothilone mixtures; substitution of this domain may change the ratios of epothilones. In addition, there are two dormant domains in module 9 of the epothilone PKS. Removing these redundant domains to generate a simpler and more efficient assembly line is a desirable goal.
RESULTS
RESULTS
The substitution of module 4 drastically diminished the activity of epothilone PKS. However, with careful design of the KS-AT linker and the post-AT linker, replacing EPOAT4 with EPOAT2, EPOAT6, EPOAT7 or EPOAT8 (specifically incorporating methylmalonyl-CoA (MMCoA)) significantly increased the ratio of epothilone D (4) to epothilone C (3) (the highest ratio of 4:3 = 4.6:1), whereas the ratio of 4:3 in the parental strain Schlegelella brevitalea 104-1 was 1.4:1. We also obtained three strains by swapping EPOAT4 with EPOAT3, EPOAT5, or EPOAT9, which specifically incorporate malonyl-CoA (MCoA). These strains produced only epothilone C, and the yield was increased by a factor of 1.8 compared to that of parental strain 104-1. Furthermore, mutations of five residues in the AT domain identified Ser310 as the critical factor for MMCoA recognition in EPOAT4. Then, the mutation of His308 to valine or tyrosine combined with the mutation of Phe310 to serine further altered the product ratios. At the same time, we successfully deleted the inactive module 9 DH and ER domains and fused the ΨKR domain with the KR domain through an ~ 25-residue linker to generate a productive and simplified epothilone PKS.
CONCLUSIONS
CONCLUSIONS
These results suggested that the substitution and deletion of catalytic domains effectively produces desirable compounds and that selection of the linkers between domains is crucial for maintaining intact PKS catalytic activity.
Identifiants
pubmed: 33882930
doi: 10.1186/s12934-021-01578-3
pii: 10.1186/s12934-021-01578-3
pmc: PMC8058987
doi:
Substances chimiques
Bacterial Proteins
0
Polyketide Synthases
79956-01-7
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
86Subventions
Organisme : National Key R&D Program of China
ID : 2020YFA0908300 & 2016YFA0500600
Organisme : National Natural Science Foundation of China
ID : 31970049
Organisme : Science and Technology Research Program of Shanghai
ID : 19DZ2282100
Références
Org Biomol Chem. 2008 Feb 7;6(3):500-6
pubmed: 18219420
ACS Chem Biol. 2013 Feb 15;8(2):443-50
pubmed: 23181268
Nat Protoc. 2015 Jun;10(6):845-58
pubmed: 25950237
Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9051-6
pubmed: 10430893
Chem Rev. 2006 Aug;106(8):3468-96
pubmed: 16895337
Fortschr Chem Org Naturst. 2009;90:29-53
pubmed: 19209840
Synth Syst Biotechnol. 2017 Sep 07;2(3):147-166
pubmed: 29318196
J Am Chem Soc. 2010 Mar 3;132(8):2469-93
pubmed: 20121095
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1802-7
pubmed: 26831085
Nat Biotechnol. 2005 Sep;23(9):1171-6
pubmed: 16116420
Nat Prod Rep. 2018 Nov 14;35(11):1185-1209
pubmed: 30074030
Nat Commun. 2018 Nov 1;9(1):4569
pubmed: 30385744
Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7839-43
pubmed: 7644502
ACS Synth Biol. 2017 Jan 20;6(1):139-147
pubmed: 27548700
Nat Prod Rep. 2018 Oct 17;35(10):1070-1081
pubmed: 29938731
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):1846-51
pubmed: 10051557
Curr Opin Struct Biol. 2013 Aug;23(4):603-12
pubmed: 23838175
Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):9259-64
pubmed: 24927540
J Nat Prod. 2001 Jul;64(7):847-56
pubmed: 11473410
Acta Biochim Biophys Sin (Shanghai). 2019 Jul 10;51(7):697-706
pubmed: 31187113
Biochemistry. 2001 Dec 25;40(51):15464-70
pubmed: 11747421
Curr Opin Struct Biol. 2016 Dec;41:10-18
pubmed: 27266330
J Ind Microbiol Biotechnol. 2003 Aug;30(8):489-94
pubmed: 12811585
Structure. 2006 Apr;14(4):737-48
pubmed: 16564177
ACS Synth Biol. 2020 Aug 21;9(8):2009-2022
pubmed: 32603592
J Biol Chem. 2016 Jul 29;291(31):16404-15
pubmed: 27246853
ACS Chem Biol. 2017 Jan 20;12(1):114-123
pubmed: 28103677
Ann Oncol. 2021 Feb;32(2):218-228
pubmed: 33188874
Angew Chem Int Ed Engl. 2009;48(26):4688-716
pubmed: 19514004
Science. 2008 Sep 5;321(5894):1315-22
pubmed: 18772430
Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4110-5
pubmed: 22371562
J Pept Sci. 2009 Dec;15(12):799-807
pubmed: 19827002
Nat Prod Rep. 2012 Oct;29(10):1050-73
pubmed: 22858605
Nat Chem Biol. 2015 Sep;11(9):660-70
pubmed: 26284673
J Antibiot (Tokyo). 2005 Mar;58(3):178-84
pubmed: 15895525
Curr Pharm Des. 2002;8(19):1707-12
pubmed: 12171542
Chem Biol. 1996 Oct;3(10):833-9
pubmed: 8939702
Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7305-9
pubmed: 9636144
J Bacteriol. 1997 Oct;179(20):6416-25
pubmed: 9335291
J Am Chem Soc. 2004 Jan 14;126(1):46-7
pubmed: 14709052
Protein Sci. 2019 Feb;28(2):414-428
pubmed: 30394635
Microb Cell Fact. 2020 Sep 15;19(1):180
pubmed: 32933531
Nature. 2016 Mar 24;531(7595):533-7
pubmed: 26976449
Chem Biol. 2014 May 22;21(5):636-46
pubmed: 24726832
Biochemistry. 1999 Feb 2;38(5):1643-51
pubmed: 9931032
Clin Cancer Res. 2008 Jul 15;14(14):4378-84
pubmed: 18628451